Octozi Raises $3M in Seed Funding to bring Agentic AI to Clinical Development – FinSMEs

Octozi has secured $3 million in seed funding to advance its agentic AI technology for clinical development applications. The funding will support the company’s efforts to integrate autonomous AI agents into the drug development process.

Read Full Article →